Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia

British Journal of Haematology

Volumn 103, Issue 2, 1998, Pages 505-511

  Elliott, Michelle A ^a   Chen, Michael G ^a   Silverstein, Murray N ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

Myelofibrosis with myeloid metaplasia; Radiation therapy; Splenomegaly

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; HUMAN; MYELOFIBROSIS; MYELOID METAPLASIA; PANCYTOPENIA; PRIORITY JOURNAL; RADIATION DOSE; SEPSIS; SPLEEN SIZE; SPLENECTOMY; SPLENOMEGALY; SURGICAL MORTALITY; SURVIVAL;

ADULT; AGED; HEMATOLOGIC DISEASES; HUMANS; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SPLENECTOMY; SPLENOMEGALY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031784441     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00998.x     Document Type: Article

References (21)

1. Anderson, J.E., Sale, G., Applebaum, F.R., Chauncey, T.R. & Storb, R. (1997) Allogeneic marrow transplantation of primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis. British Journal of Haematology, 98, 1010-1016.
2. Barosi, G., Ambrosetti, A., Buratti, A., Finelli, C., Liberato, N.L., Quaglini, S., Recetti, M.M., Visani, G., Tura, S. & Ascari, E. (1993) Splenectoniy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia, 7, 200-206.
3. Benbassat, J., Gilon, D. & Penchas, S. (1990) The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia. American Journal of Hematoloay, 33, 128-135.
4. Dameshek, W. (1951) Some speculations on the myeloproliferative syndromes. Blood, 6, 372-375.
5. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. & Baulers, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-1018.
6. Gardner, F.H. & Nathan, D.G. (1966) Androgens and erythropoiesis. 3. Further evaluation of testosterone treatment of myelofibrosis. New England Journal of Medicine, 274, 420-426.
7. Gilbert, U.S. (1973) The spectrum of myeloproliferative disorders. Medical Clinics of North America, 57, 355-393.
8. Greenberger, J.S., Chaffey, J.T., Rosenthal, D.S. & Moloney, W.C. (1977) Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasia. International Journal of Radiation Oncology, Biology, Physics, 2, 1083-1090.
9. Hernandez, J.M., San Miguel, J.F., Gonzalez, M., Orfao, A., Canizo, M.C., Bascones, C., Hernandez, J. & Lopez Borrasca, A. (1992) Development of acute leukaemia after idiopathic myelofibrosis. Journal of Clinical Pathology, 45, 427-430.
10. Lofvenberg, E. & Wahlin, A. (1988) Management of polycythaemia vera. essential thrombocythaemia and myelofibrosis with hydroxyurea. European Journal of Haematology, 41, 375-381.
11. Malmaeus, J., Akre, T., Adami, H.O. & Hagberg, H. (1986) Early postoperative course following elective splenectomy in haematological diseases: a high complication rate in patients with myeloproliferative disorders. British Journal of Surgery, 73, 720-723.
12. Manoharan, A. (1991) Management of myelofibrosis with intermittent hydroxyurea. British Journal of Haematology, 77, 252-254.
13. Parmentier, C., Charbord, P., Tibi, M. & Tubiana, M. (1977) Splenic irradiation in myelofibrosis: clinical findings and ferrokinetics. International Journal of Radiation Oncology, Biology, Physics, 2, 1075-1081.
14. Reilly, J.T. (1994) Pathogenesis of idiopathic myelofibrosis: present status and future directions. British Journal of Haematology, 88, 1-8.
15. Silverstein, M.N. (1976) The evolution into and the treatment of late stage polycythemia vera. Seminars in Hematology, 13, 79-84.
16. Silverstein, M.N., Brown, A.L., Jr & Linman, J.W. (1973) Idiopathic myeloid metaplasia: its evolution into acute leukemia. Archives of Internal Medicine, 132, 709-712.
17. Silverstein, M.N. & ReMine, W.H. (1979) Splenectomy in myeloid metaplasia. Blood, 53, 515-518.
18. Slanina, J., Vondraczek, A. & Wannenmacher, M. (1986) Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis. Deutsche Medizinische Wochenschrift, 111, 1144-1150.
19. Tefferi, A., Silverstein, M.N. & Noel, P. (1995) Agnogenic myeloid metaplasia. Seminars in Oncology, 22, 327-333.
20. Visani, G., Finelli, C., Castelli, U., Petti, M.C., Ricci, P., Vianelli, N., Gianni, L., Zuffa, E., Aloe Spiriti, M.A., Latagliata, R., Pileri, S., Magrini, U., Gugliotta, L., Morra, E., Bernasconi, C., Mandelli, F. & Tura, S. (1990) Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. British Journal of Haematology, 75, 4-9.
21. Wagner, H., Jr. McKeough, P.G., Desforges, J. & Madoc-Jones, H. (1986) Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia: results of daily and intermittent fractionation with and without concomitant hydroxyurea. Cancer, 58, 1204-1207.